Comparing electrical stimulation and capsicum plaster for pregnancy-related nausea
Effect of Transcutaneous Electrical Nerve Stimulation Versus Capsicum Plaster on Emesis Gravidarum
NA · Cairo University · NCT06520735
This study is testing whether electrical stimulation or capsicum plaster can help pregnant women with nausea and vomiting feel better during their first trimester.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 20 Years to 35 Years |
| Sex | Female |
| Sponsor | Cairo University (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06520735 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of transcutaneous electrical nerve stimulation (TENS) and capsicum plaster in treating emesis gravidarum, a common condition affecting pregnant women. The research will involve pregnant women aged 20 to 35 who experience mild to moderate nausea and vomiting during their first trimester. Participants will receive either TENS at the Nei-Guan P6 acupoint or capsicum plaster applied to acupuncture points to assess which method provides better relief from symptoms. The study will help determine a non-pharmacological approach to managing nausea in pregnancy.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women aged 20 to 35 with mild to moderate nausea and vomiting before 20 weeks of gestation.
Not a fit: Patients with severe nausea and vomiting (hyperemesis gravidarum) or those with a history of nausea before pregnancy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide pregnant women with effective non-drug options for managing nausea and vomiting.
How similar studies have performed: Previous studies have shown that both transcutaneous electrical stimulation and capsicum plaster can be effective in managing nausea, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women complaining of emesis gravidarum * Their ages will be ranged from 20 to 35 years old. * Their body mass index will not exceed 35 kg/ m2. * Their gestational age will be less than 20 weeks. * All women having mild to moderate nausea and/or vomiting * All women having singleton pregnancy Exclusion Criteria: Women will be excluded from the study if they have: * Previous carpal tunnel syndrome. * Skin abnormalities * Acute viral disease * Hyperemesis gravidarum. * Previous history of nausea or vomiting before pregnancy.
Where this trial is running
Cairo
- Peter Bahgat Milad — Cairo, Egypt (RECRUITING)
Study contacts
- Study coordinator: Peter Milad, PHD
- Email: Peterbahgat280@gmail.com
- Phone: +201002980392
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Emesis Pregnancy